Chloroquine for Malaria in Pregnancy

PHASE3CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

January 31, 2015

Conditions
Malaria
Interventions
DRUG

Chloroquine

Chloroquine tablets contain 300 mg chloroquine base per tablet. Dosages: Chloroquine 1,500 mg base over 3 days twice during pregnancy or Chloroquine 600 mg loading dose followed by 300 mg orally once per week. Intermittant preventative treatment in pregnancy (IPTp) doses will be administered between weeks 20-28 and weeks 28-34 gestation, 4 weeks apart. Participants randomized to IPTp with chloroquine will require their second and third doses of chloroquine after the initial dose given in the clinic and those assigned to chloroquine chemoprophylaxis will require weekly doses.

DRUG

Sulfadoxine-pyrimethamine

Sulfadoxine-pyrimethamine 3 tablets (1,500 mg sulfadoxine and 75 mg pyrimethamine) twice during pregnancy. Intermittant preventive treatment in pregnancy (IPTp) doses will be administered between weeks 20-28 and weeks 28-34, 4 weeks apart.

Trial Locations (1)

Unknown

Blantyre Malaria Project - Queen Elizabeth Central Hospital, Blantryre

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01443130 - Chloroquine for Malaria in Pregnancy | Biotech Hunter | Biotech Hunter